Vincere Biosciences
PrivateLast Round
Grant
Nov 18, 2025
Total Funding Raised
$7.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vincere Biosciences is a biotechnology company that develops small molecule therapeutics to treat age-related diseases, such as Parkinson's, by enhancing mitochondrial quality control.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vincere Biosciences Comparables
Compare Vincere Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Casma Therapeutics | 87% | |
| Mission Therapeutics | 86% | |
| Pretzel Therapeutics | 79% |
Vincere Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 18, 2025 | ||||
| Strategic | May 22, 2025 | ||||
| Grant | Sep 25, 2023 | ||||
| Strategic | Jun 12, 2023 | ||||
| Grant | Jun 27, 2022 | ||||
Grant | Apr 13, 2020 |
Vincere Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Grant |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| National Institute on Aging | Grant |
| Draper Associates | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 236% MoM, reaching 3.1K.
- Nov 18, 2025
Secured $5M in grant funding.
Recent news
Latest coverage and updates
- receives_financingSep 14, 2026
Vincere Biosciences Inc received financing of $2.7M in Small Business Innovation Research Phase II grant on Sep 14th '26.
Vincere Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vincere Biosciences's valuation, stock price, and market status.
Is Vincere Biosciences a public or private company?
Vincere Biosciences is a private company.
What is the current stock price of Vincere Biosciences?
Vincere Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Vincere Biosciences worth (valuation)?
Valuation information for Vincere Biosciences is not publicly available.
Can I buy Vincere Biosciences stock?
Vincere Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vincere Biosciences's last funding round?
Vincere Biosciences's most recent funding round was Grant on November 18, 2025.
Who are the main investors in Vincere Biosciences?
Key investors in Vincere Biosciences include The Michael J. Fox Foundation for Parkinson's Research, National Institute on Aging, National Institute of Neurological Disorders and Stroke.
Will Vincere Biosciences IPO soon?
No public IPO plans have been announced for Vincere Biosciences.
How can I track Vincere Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vincere Biosciences's secondary market activity and sign up for updates.